11:39 AM EST - Abattis Bioceuticals Corp. : Announced that Health Canada has approved an amendment to the dealer’s license held by Northern Vine Canada. Northern Vine is a subsidiary of Abattis and Emerald Health Therapeutics. The amendment to the dealer’s license gives Northern Vine the ability to transport, deliver and sell product to other Licensed Dealers, authorized persons under the Controlled Drug and Substances Act (Canada) and Licensed Producers. While Northern Vine was previously authorized to conduct activities related to analytical testing, extraction, and import/export, this amendment allows it to broaden its business opportunities through the production and sale of downstream cannabis products, such extracts and isolates. Abattis Bioceuticals Corp.
shares ATT:CNX are trading up 4 cents at $0.60.
